We review your weight goals, medical history, current height and weight, and whether treatment may be suitable
Your firm should take prompt action to address any violations identified in this letter, the FDA wrote
Systemic Side Effects Gastrointestinal Side Effects The most commonly reported side effects of GLP-1 RAs are gastrointestinal, including nausea, vomiting, diarrhea, constipation, abdominal pain, and dyspepsia [113,114,115]
Patients inject the medication in the abdomen, thigh, or upper arm and rotate injection sites with each dose
[8] [9] The ability of orforglipron to reduce blood sugar levels and body weight was judged favorable compared to dulaglutide